Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia

This publication has 15 references indexed in Scilit:

• Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
  New England Journal of Medicine, 2022
• Romiplostim in aplastic anaemia – another tool in the armamentarium
  British Journal of Haematology, 2020
• High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag
  Leukemia, 2020
• Prospective randomized trial comparing two doses of rabbit anti‐thymocyte globulin in patients with severe aplastic anaemia
  British Journal of Haematology, 2019
• Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy
  International Journal of Hematology, 2019
• Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review
  Expert Review of Hematology, 2017
• Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
  New England Journal of Medicine, 2017
• Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia
  International Journal of Hematology, 2017
• Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
  New England Journal of Medicine, 2012
• Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
  New England Journal of Medicine, 2011